ACTION: a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma.
Arrillaga-Romany I, Lassman A, McGovern SL, Mueller S, Nabors B, van den Bent M, Vogelbaum MA, Allen JE, Melemed AS, Tarapore RS, Wen PY, Cloughesy T.
Arrillaga-Romany I, et al. Among authors: tarapore rs.
Neuro Oncol. 2024 May 3;26(Supplement_2):S173-S181. doi: 10.1093/neuonc/noae031.
Neuro Oncol. 2024.
PMID: 38445964
Free PMC article.
Clinical Trial.